126 related articles for article (PubMed ID: 26010984)
1. A case of intravascular lymphoma diagnosed in an explanted liver after liver transplantation.
Kuramitsu K; Fukumoto T; Yano Y; Hirano H; Misumi T; Katayama Y; Kawano H; Yakushijin K; Zen Y; Itoh T; Ku Y
Transpl Int; 2015 Oct; 28(10):1245-50. PubMed ID: 26010984
[TBL] [Abstract][Full Text] [Related]
2. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
3. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Dai MS; Chao TY; Kao WY; Shyu RY; Liu TM
Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
[TBL] [Abstract][Full Text] [Related]
4. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Pfreundschuh M; Schubert J; Ziepert M; Schmits R; Mohren M; Lengfelder E; Reiser M; Nickenig C; Clemens M; Peter N; Bokemeyer C; Eimermacher H; Ho A; Hoffmann M; Mertelsmann R; Trümper L; Balleisen L; Liersch R; Metzner B; Hartmann F; Glass B; Poeschel V; Schmitz N; Ruebe C; Feller AC; Loeffler M;
Lancet Oncol; 2008 Feb; 9(2):105-16. PubMed ID: 18226581
[TBL] [Abstract][Full Text] [Related]
5. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
6. [Intravascular lymphomatosis manifesting clinically as subacute encephalopathy].
Tsuji H; Mochiduki A; Hosaka A; Yoshizawa T; Tamaoka A
Rinsho Shinkeigaku; 2008 May; 48(5):328-32. PubMed ID: 18540379
[TBL] [Abstract][Full Text] [Related]
7. Primary cardiac diffuse large B-cell lymphoma with activated B-cell-like phenotype.
Gadage V; Kembhavi S; Kumar P; Shet T
Indian J Pathol Microbiol; 2011; 54(3):591-3. PubMed ID: 21934230
[TBL] [Abstract][Full Text] [Related]
8. Remission of Late-Onset Post-Liver Transplantation Non-Hodgkin Lymphoma.
Stardelova KG; Stojanovik A; Jovanovska RP; Stavrik S; Dimitrova M; Kostova NM; Serafimoski V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):67-71. PubMed ID: 31152642
[TBL] [Abstract][Full Text] [Related]
9. Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.
Stange MA; Tutarel O; Pischke S; Schneider A; Strassburg CP; Becker T; Barg-Hock H; Bastürk M; Wursthorn K; Cornberg M; Ott M; Greten TF; Manns MP; Wedemeyer H
Z Gastroenterol; 2010 Feb; 48(2):258-63. PubMed ID: 20127601
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
11. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
Habermann TM; Weller EA; Morrison VA; Gascoyne RD; Cassileth PA; Cohn JB; Dakhil SR; Woda B; Fisher RI; Peterson BA; Horning SJ
J Clin Oncol; 2006 Jul; 24(19):3121-7. PubMed ID: 16754935
[TBL] [Abstract][Full Text] [Related]
12. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
[TBL] [Abstract][Full Text] [Related]
13. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
Raderer M; Wohrer S; Streubel B; Drach J; Jager U; Turetschek K; Troch M; Puspok A; Zielinski CC; Chott A
Oncology; 2006; 70(6):411-7. PubMed ID: 17220639
[TBL] [Abstract][Full Text] [Related]
14. Intravascular lymphoma presenting as telangectasias: response to rituximab and combination chemotherapy.
Weichert G; Martinka M; Rivers JK
J Cutan Med Surg; 2003; 7(6):460-3. PubMed ID: 14605917
[TBL] [Abstract][Full Text] [Related]
15. Multiple Cerebral Hemorrhages With Microbleeds in Intravascular Large B-Cell Lymphoma.
Kimura M; Fujiwara S; Tanaka A; Omura Y; Yamashita D; Hinoda T; Sakai N; Kohara N
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104798. PubMed ID: 32249205
[TBL] [Abstract][Full Text] [Related]
16. [Intravascular lymphoma confirmed by brain biopsy, quickly treated by chemotherapy: a case report].
Inoue D; Hamamura T; Uehara T; Miyoshi K; Katsuragi T; Takeshita I; Hamada T
No Shinkei Geka; 2009 Apr; 37(4):369-74. PubMed ID: 19364028
[TBL] [Abstract][Full Text] [Related]
17. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.
Park YH; Lee JJ; Ryu MH; Kim SY; Kim DH; Do YR; Lee KH; Oh SJ; Kim YK; Suh CW; Heo DS; Ryoo BY; Kim JK; Song HS; Lee WS; Kim HJ; Bang YJ; Yang SH; Sohn SK; Kang YK;
Ann Hematol; 2006 Apr; 85(4):257-62. PubMed ID: 16416337
[TBL] [Abstract][Full Text] [Related]
18. Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.
Ziepert M; Hasenclever D; Kuhnt E; Glass B; Schmitz N; Pfreundschuh M; Loeffler M
J Clin Oncol; 2010 May; 28(14):2373-80. PubMed ID: 20385988
[TBL] [Abstract][Full Text] [Related]
19. [Standard CHOP immuno-chemotherapy for primary mediastinal lymphomas].
Schneider T; Tóth E; Lovey J; Molnár Z; Deák B; Várady E; Csomor J; Matolcsy A; Lengyel Z; Petri K; Gaudi I; Rosta A
Orv Hetil; 2011 May; 152(19):735-42. PubMed ID: 21498163
[TBL] [Abstract][Full Text] [Related]
20. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
Akhtar S; Maghfoor I
N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
